Navigation Links
Amicus Therapeutics to Present at the 2008 BioCentury NewsMakers in the Biotech Industry Conference
Date:8/29/2008

CRANBURY, N.J., Aug. 29 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD), today announced Chief Operating Officer Matthew Patterson will make a presentation at the BioCentury NewsMakers in the Biotech Industry Conference on Thursday, September 4, 2008 at 2:30 p.m. EDT in Room 402/403 with a breakout session immediately following the presentation in Room 401. The conference will be held at Millennium Broadway Hotel & Conference Center in New York.

A webcast and audio archive of the presentation will be available at http://www.amicustherapeutics.com. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the Company's Web site for 30 days until October 4, 2008.

About Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera for the treatment of Gaucher disease and AT2220 for the treatment of Pompe disease.

FOLD-G


'/>"/>
SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Amicus Therapeutics Announces Second Quarter 2008 Results Release Date
2. Amicus Therapeutics Announces First Quarter 2008 Financial Results
3. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
4. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
5. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
6. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
9. Amicus Therapeutics to Host R&D Day
10. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
11. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2014)... The Asia-Pacific Liquid Crystal on Silicon (LCoS) display ... Asia-Pacific with analysis and forecast of revenue. This market ... expected to reach $380.0 million by 2018, at a ... through the TOC of the Asia-Pacific LCoS display market ... provided. This also provides a glimpse of the segmentation ...
(Date:10/18/2014)... (PRWEB) October 18, 2014 According to ... Resource & Well Type - Global Trends & Forecasts ... estimated $31 billion in 2011. This value is expected ... billion by 2017, with 10% CAGR during the same ... hydraulic fracturing production market in terms of hydraulic horse ...
(Date:10/17/2014)... a $451,781 Air Force Office of Scientific Research grant ... nano-scale level that will provide clues for predicting fatigue ... Aerospace Engineering, said the new technology and process would ... an aircraft,s wing., "We,ll be able to determine metal ... it on this scale," Huang said. "Certain patterns of ...
(Date:10/17/2014)... For the seventh consecutive year, ... in today’s print issue of Science magazine. , ... Survey polled employees in the biotechnology, pharmaceutical and ... Rankings were determined based on responses from ... companies on 23 characteristics, including financial strength, leadership ...
Breaking Biology Technology:The Asia-Pacific Liquid Crystal on Silicon (LCoS) display market is expected to reach $380.0 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Liquid Crystal on Silicon (LCoS) display market is expected to reach $380.0 million by 2018 - New Report by MicroMarket Monitor 3Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 2Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 3Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 4UT Arlington project to detect possible damages in aircraft parts early in process 2DuPont Named Top Employer by Science Magazine 2DuPont Named Top Employer by Science Magazine 3
... CITY, Dec. 4 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... company focused on endocrine therapy and oncology, today announced ... take part in a panel discussion titled, "Replacing The ... RBC Capital Markets 2008 Healthcare Conference on Wednesday, December ...
... and secondhand smoke, an estimated ten percent of pregnant women ... baby to harmful cigarette byproducts from mothers who smoke affects ... health care burden. , Now, in the first study of ... assessment of newborns, umbilical cord blood to better understand the ...
... Dec. 3 CeloNova BioSciences, Inc., announced,today that ... is commercializing the,CATANIA(TM) Coronary Stent System with NanoThin ... any stent thrombosis in clinical studies. It is ... now some Middle,Eastern countries with aggressive world-wide expansion ...
Cached Biology Technology:Cutting the cord to determine babies' health risk from toxic exposure 2Cutting the cord to determine babies' health risk from toxic exposure 3Cutting the cord to determine babies' health risk from toxic exposure 4CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 2CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 3
(Date:10/17/2014)... Ebola is critical and pertinent for practicing physicians and ... and epidemic. The Journal, Disaster Medicine and Public ... Virus and Public Health, to surround the public, medical ... societal moment. , On October 17, the journal ... The primer was prepared by Dr. Eric Toner, internist ...
(Date:10/16/2014)... war on the human body. Battles are won, ... pancreatic cancer, this stalemate—known as tumor dormancy—can last ... a phenomena that is poorly understood. , ... of Salvatore Torquato, a Professor of Chemistry at ... tumor dormancy and the switch to a malignant ...
(Date:10/16/2014)... they are anything but sustainable: environmental damage to ... becoming increasingly evident. Despite their disadvantages, however, monocultures ... as the sole possibility of achieving higher yields ... Schmid, an ecology professor at the University of ... and forestry. After all, a new study carried ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3
... method could enable scientists to generate snapshots of dozens of ... team from the Wyss Institute of Biologically Inspired Engineering at ... Such images could shed light on complex cellular pathways ... its prognosis, or monitor the effectiveness of therapies at a ...
... of East Anglia is launching a project to predict how ... sea ice chamber and using state-of-the-art computer models. The ... ocean, sea ice, snow and the atmosphere in polar regions. ... the European Research Council (ERC). Lead researcher Prof Roland ...
... neurodevelopmental disorders, different parts of the brain don,t talk ... for the first time, a way in which this ... published online today in Nature Neuroscience , scientists ... Italy, and collaborators at the Istituto Italiano di Tecnologia ...
Cached Biology News:Capturing ultrasharp images of multiple cell components at once 2Capturing ultrasharp images of multiple cell components at once 3€2M EU funding for UEA project to understand Arctic ice melt 2Making your brain social 2
... The EZ DNA Methylation Kit uses ... method for DNA methylation analysis. The kit ... that takes place between cytosine and sodium ... The EZ DNA Methylation Kits innovative in-column ...
... The DIGIVIEW line of digital x-ray ... radiation imaging device complete with 12 to ... area consists of a photodiode array sensor ... All models are available in low x-ray ...
... on rat tissue extracts (liver, kidney, spleen, and ... ) extract. It was also tested with microsomal ... Application: A simple and reliable method for measuring ... detection of the inorganic phosphate released from NDP ...
... BTX, the leader in electroporation products and ... innovative product line for experiment optimization and ... is a breakthrough in Molecular Delivery. The ... procedures that typically limited the number of ...
Biology Products: